QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
QQQ   277.84 (+0.68%)
AAPL   115.81 (+1.51%)
MSFT   210.33 (+1.48%)
FB   261.90 (+0.04%)
GOOGL   1,465.60 (-0.03%)
AMZN   3,148.73 (+0.12%)
TSLA   429.01 (+2.37%)
NVDA   541.22 (+2.30%)
BABA   293.98 (+6.16%)
CGC   14.32 (-1.24%)
MU   46.96 (-7.39%)
GE   6.23 (+1.80%)
AMD   81.99 (+0.27%)
T   28.51 (+0.74%)
F   6.66 (+0.91%)
ACB   4.65 (-0.64%)
GILD   63.19 (+1.76%)
NFLX   500.03 (+1.33%)
DIS   124.08 (-1.05%)
BA   165.26 (+1.01%)
BAC   24.09 (+1.35%)
Log in
NASDAQ:PETQ

PetIQ Stock Forecast, Price & News

$32.92
+0.14 (+0.43 %)
(As of 09/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$32.48
Now: $32.92▼
$33.50
50-Day Range
$29.04
MA: $31.73▼
$35.35
52-Week Range
$15.83
Now: $32.92▼
$38.99
Volume220,323 shs
Average Volume389,518 shs
Market Capitalization$940.59 million
P/E RatioN/A
Dividend YieldN/A
Beta1.55
PetIQ, Inc. operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats. The company offers Rx pet medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; and OTC medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars. It also provides health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company offers its products primarily under the PetIQ, PetAction Plus, Advecta, PetLock Plus, and TruProfen brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers across 39 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It sells its products through approximately 60,000 points of distribution across retail and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
Read More
PetIQ logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.58 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Drugs, proprietaries, & sundries
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PETQ
Previous Symbol
CUSIPN/A
CIK1668673
Webwww.petiq.com
Phone208-939-8900

Debt

Debt-to-Equity Ratio1.04
Current Ratio3.06
Quick Ratio2.17

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio47.71
P/E Growth1.81

Sales & Book Value

Annual Sales$709.43 million
Price / Sales1.33
Cash Flow$1.51 per share
Price / Cash Flow21.76
Book Value$11.60 per share
Price / Book2.84

Profitability

EPS (Most Recent Fiscal Year)$1.07
Net Income$-11,450,000.00
Net Margins-2.63%
Return on Equity8.52%
Return on Assets3.85%

Miscellaneous

Employees1,866
Outstanding Shares28,572,000
Market Cap$940.59 million
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
$32.92
+0.14 (+0.43 %)
(As of 09/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PETQ News and Ratings via Email

Sign-up to receive the latest news and ratings for PETQ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











PetIQ (NASDAQ:PETQ) Frequently Asked Questions

How has PetIQ's stock price been impacted by Coronavirus (COVID-19)?

PetIQ's stock was trading at $22.59 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PETQ stock has increased by 45.7% and is now trading at $32.92.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of PetIQ?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for PetIQ.

When is PetIQ's next earnings date?

PetIQ is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for PetIQ.

How were PetIQ's earnings last quarter?

PetIQ Inc (NASDAQ:PETQ) posted its quarterly earnings results on Thursday, August, 6th. The company reported $0.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.44 by $0.26. The company had revenue of $266.98 million for the quarter, compared to analysts' expectations of $251.20 million. PetIQ had a positive return on equity of 8.52% and a negative net margin of 2.63%.
View PetIQ's earnings history.

What guidance has PetIQ issued on next quarter's earnings?

PetIQ issued an update on its third quarter 2020 After-Hours earnings guidance on Thursday, August, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $160-170 million, compared to the consensus revenue estimate of $205.77 million.

What price target have analysts set for PETQ?

4 brokerages have issued twelve-month target prices for PetIQ's stock. Their forecasts range from $43.00 to $175.00. On average, they expect PetIQ's share price to reach $78.25 in the next twelve months. This suggests a possible upside of 137.7% from the stock's current price.
View analysts' price targets for PetIQ.

Are investors shorting PetIQ?

PetIQ saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 5,460,000 shares, an increase of 17.9% from the August 15th total of 4,630,000 shares. Based on an average daily trading volume, of 433,300 shares, the short-interest ratio is presently 12.6 days.
View PetIQ's Short Interest.

Who are some of PetIQ's key competitors?

Some companies that are related to PetIQ include Nu Skin Enterprises (NUS), (BTCA) (BTCA), Trxade Group (TRXD), MultiCell Technologies (MEDS), biOasis Technologies (BIOAF), China Medicine (CHME) and Medizone International (MZEIQ).
View all competitors.

What other stocks do shareholders of PetIQ own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), CVS Health (CVS), Intel (INTC), QUALCOMM (QCOM), Editas Medicine (EDIT) and Gilead Sciences (GILD).

Who are PetIQ's key executives?

PetIQ's management team includes the following people:
  • Mr. McCord Christensen, Chairman & CEO (Age 47)
  • Ms. Susan Sholtis, Pres (Age 53)
  • Mr. John Newland, Chief Financial Officer (Age 55)
  • Mr. Robert Michael Herrman, Gen. Counsel & Sec.
  • Mr. Adam Fellers, Sr. VP of Sales

When did PetIQ IPO?

(PETQ) raised $86 million in an initial public offering (IPO) on Friday, July 21st 2017. The company issued 5,700,000 shares at a price of $14.00-$16.00 per share. Jefferies and William Blair served as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

What is PetIQ's stock symbol?

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

How do I buy shares of PetIQ?

Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is PetIQ's stock price today?

One share of PETQ stock can currently be purchased for approximately $32.92.

How big of a company is PetIQ?

PetIQ has a market capitalization of $940.59 million and generates $709.43 million in revenue each year. The company earns $-11,450,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. PetIQ employs 1,866 workers across the globe.

What is PetIQ's official website?

The official website for PetIQ is www.petiq.com.

How can I contact PetIQ?

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]

This page was last updated on 9/30/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.